Oruka Therapeutics (ORKA) Operating Income Growth (1y) (2011 - 2024)
Oruka Therapeutics (ORKA) Operating Income Growth (1y) (2011 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,719.23 Bn | 65,718.94 Bn | - | -24.89% |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 471.85 Bn | 467.06 Bn | 1.35 Bn | 2,150.96% |
| 5 | Vertex Pharmaceuticals | 122.29 Bn | 115.04 Bn | 2.59 Bn | 80.62% |
| 6 | Regeneron Pharmaceuticals | 70.04 Bn | 61.28 Bn | 3.31 Bn | 8.65% |
| 7 | Belite Bio | 62.06 Bn | 62.06 Bn | - | - |
| 8 | Argenx Se | 55.78 Bn | 50.60 Bn | 1.41 Bn | 145.20% |
| 9 | Alnylam Pharmaceuticals | 37.47 Bn | 34.47 Bn | 959.66 Mn | 1,386.07% |
| 10 | Oruka Therapeutics | 949.16 Mn | 118.01 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -58.24% |
| Mar 31, 2024 | -38.20% |
| Dec 31, 2023 | -2.71% |
| Sep 30, 2023 | 24.10% |
| Jun 30, 2023 | 38.71% |
| Mar 31, 2023 | 45.19% |
| Dec 31, 2022 | 72.75% |
| Sep 30, 2022 | 45.89% |
| Jun 30, 2022 | 33.45% |
| Mar 31, 2022 | 20.11% |
| Dec 31, 2021 | -10.81% |
| Sep 30, 2021 | -136.98% |
| Jun 30, 2021 | -269.24% |
| Mar 31, 2021 | -206.12% |
| Dec 31, 2020 | -301.10% |
| Sep 30, 2020 | -59.58% |
| Jun 30, 2020 | 13.13% |
| Mar 31, 2020 | 24.76% |
| Dec 31, 2019 | 16.31% |
| Sep 30, 2019 | 24.97% |